Image For Activity Cover
SCAI Interactive CME Mini-Series - Technical Mastery: Guidance on Proper Imaging, Lesion Preparation, and Deployment for Coronary Drug-Coated Balloons
How to Register
  1. To register, press the "Get Started" button.
  2. Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login.”
  3. Once registered, you will see a screen where you can add the webinar to your calendar.
  4. After registering for the series, select each session you'd like to attend and click "Register."
Credit Claim
To claim credit you must register for each session in the series, attend the webinars, and complete the evaluation. Each webinar in the series is worth 1 CME/ ABIM MOC credits, with a total of 3 CME/ ABIM MOC credits available.
Series Overview
This webinar mini-series will be held in three parts and moderated by Drs. Sahil A. Parikh, Azeem Latib, and Ziad Ali. Faculty will present lectures and share cases to illustrate the utility of drug coated ballons (DCBs) in a variety of cardiac treatments.

DCBs are an example of advanced technology that can be used to treat CAD and PAD cases. DCBs may be especially helpful in CAD cases when there is concern about restenosis. In some cases, DCBs have shown efficacy in reducing the rates of restenosis compared to traditional angioplasty alone. Research has also shown that in some cases, DCBs can be used without the need for additional stent placement, reducing the risks associated with stent implantation and offering another patient treatment option for difficult to treat cases.

Register now for entire series.
Session Details
Session Date Credit
Webinar 1 | In-Stent Restenosis, Step-by-Step How to Treat Aug 27 1 CME/ABIM MOC
Webinar 2 | Coronary DCBs in De Novo Lesions, Small Vessel, and Bifurcation: The European Experience Sept 6 1 CME/ABIM MOC
Webinar 3 | Bringing it All Together: Case Reviews of In-Stent Restenosis Sept 24 1 CME/ABIM MOC
Faculty

 

Ziad A. Ali, MD, PhD, FSCAI

Moderator

Azeem Latib, MD, FSCAI

Moderator

Sahil A. Parikh, MD, FSCAI

Moderator


J. Dawn Abbott, MD, MSCAI

Wayne B. Batchelor, MD, FSCAI

Antonio Colombo, MD, MSCAI

Bernardo Cortese, MD, FSCAI

Kevin J. Croce, MD, PhD, FSCAI

Yuji Ikari, MD, PhD

Kathleen Kearney, MD, FSCAI

Emily Larnard, MD

Margaret McEntegart, MD, PhD

 

Acknowledgment of Commercial Support
This activity is supported by an unrestricted educational grant from Boston Scientific.
Learning Objectives
Upon completion of this mini-series, participants will be able to:
  • Discuss key data from coronary drug-coated balloon (DCB) clinical trials and their implications for clinical practice.
  • Select appropriate patients for coronary DCB’s.
  • Plan for deployment of coronary DCB’s, including step-by-step imaging guidance and lesions preparation.
  • Examine cases of in-stent restenosis (ISR), including single-layer, double-layer, and stent failure. 
  • Explore other evidence-based applications of coronary DCB’s.
Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography & Interventions (SCAI) is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process 
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins. 

Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations.

All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis. 

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services.

Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.

Copyright
© 2025 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Summary
Availability:
Registration Required
Access expires on Aug 26, 2025
Location:
Online Meeting
Date / Time:
Aug 27, 2025 6:00 PM - 7:00 PM ET
Other Date / Time:
Sep 06, 2025 10:00 AM - 11:00 AM ET
Sep 24, 2025 6:00 PM - 7:00 PM ETs
Cost:
FREE
Credit Offered:
3 CME Credits
3 ABIM-MOC Points
3 Participation Credits
Powered By